Cytokinetics reported $-54254000 in EBITDA for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebitda Change
Acadia Pharmaceuticals ACAD:US $ -14.32M 28.46M
Acceleron Pharma XLRN:US $ -69.47M 6.84M
Amgen AMGN:US $ 3228M 40M
Arca Biopharma ABIO:US $ -4.1M 2.11M
Bayer BAYN:GR € 2089M 946M
Biogen BIIB:US $ 991.8M 155.8M
Brainstorm Cell Therapeutics BCLI:US $ -5.21M 0.85M
Bristol Myers Squibb BMY:US $ 5712M 33M
Eisai 4523:JP Y 15346M 49516M
Eli Lilly And LLY:US $ 2437.5M 639.8M
Exelixis EXEL:US $ 56.42M 70.25M
Genocea Biosciences GNCA:US $ -11.32M 2.86M
Geron GERN:US $ -25.62M 3.22M
Halozyme Therapeutics HALO:US $ 76.34M 17.51M
Intra Cellular Therapies ITCI:US $ -77.19M 8.17M
Ligand Pharmaceuticals LGND:US $ 28.43M 29.92M
Novartis NOVN:VX SF 4837M 65M
Pfizer PFE:US $ 10235M 2245M
Regeneron Pharmaceuticals REGN:US $ 1920.4M 1497.9M